-
The presence of treatment-resistant hypertension implies an increased cardiovascular risk and can be caused or favoured by old age, obesity, diabetes and chronic renal diseases. In order to effectively face this situation, endothelin was considered, a powerful vasoconstrictor, which can have an important role in resistant hypertension: darusetan, not approved by FDA yet, is an experimental endothelin antagonist.
MedNews (Cardiologia) - Mar, 31 Agosto 2010
http://mn.medsurfnews.com/
-
What Is Important and to Whom?
The association between procedural volume and short-term mortality has been repeatedly demonstrated for coronary artery bypass graft (CABG) surgery.1-3 By virtue of this association it has been proposed that procedural volume, which can be easily measured, be used as a surrogate for quality, which is difficult to define and measure.
Archives of Internal Medicine (Cardiologia) - Mar, 31 Agosto 2010
http://archinte.ama-assn.org/
-
The US Food and Drug Administration (FDA) has approved the first generic version of enoxaparin sodium injection, an anticoagulant used to prevent potentially fatal deep vein thrombosis.
Journal of the American Medical Association (Cardiologia) - Mar, 31 Agosto 2010
http://jama.ama-assn.org/
-
The prevalence of atrial fibrillation (AF) is related to age and is projected to rise exponentially as the population ages and the prevalence of cardiovascular risk factors increases. The risk of ischemic stroke is significantly increased in AF patients, and there is evidence of a graded increased risk of stroke associated with advancing age.
Journal of the American College of Cardiology (Cardiologia) - Mar, 31 Agosto 2010
http://content.onlinejacc.org/
-
Biventricular resynchronization, a therapy recommended for patients presenting with left ventricular (LV) dysfunction and ventricular dyssynchrony, requires the implantation of an LV lead, usually placed in a lateral or posterolateral tributary of the coronary sinus. Despite important progress made in the development of dedicated instrumentation, the procedure remains sometimes challenging and unsuccessful in a minority of patients.
Journal of the American College of Cardiology (Cardiologia) - Mar, 31 Agosto 2010
http://content.onlinejacc.org/
-
Cardiac resynchronization therapy (CRT) is an effective treatment for patients with drug-refractory, chronic heart failure. Multiple single-center and multicenter studies have shown significant reductions in left ventricular (LV) volumes and an increase in LV systolic function.
Journal of the American College of Cardiology (Cardiologia) - Mar, 31 Agosto 2010
http://content.onlinejacc.org/
-
The presence of treatment-resistant hypertension implies an increased cardiovascular risk and can be caused or favoured by old age, obesity, diabetes and chronic renal diseases. In order to effectively face this situation, endothelin was considered, a powerful vasoconstrictor, which can have an important role in resistant hypertension: darusetan, not approved by FDA yet, is an experimental endothelin antagonist.
MedNews (Cardiologia) - Lun, 26 Luglio 2010
http://mn.medsurfnews.com/
-
The values of B-natriuretic peptide (BNP) are often used to distinguish a heart-related dyspnea from other causes, but, beside heart failure, some further characteristics of the patient can influence the values of this parameter. In order to clear the problem up, a retrospective analysis has been performed in a Veterans Affairs Medical Center, examining the data from 335 subjects arrived at the emergency department during the year 2007 because of dyspnea.
MedNews (Cardiologia) - Gio, 22 Luglio 2010
http://mn.medsurfnews.com/
-
Many patients at high risk of stroke are not getting the specialist treatment they need, an audit found.
BBC News (Cardiologia) - Gio, 22 Luglio 2010
http://news.bbc.co.uk
-
NICE has published its final draft guidance on the use of dronedarone which reaffirms the decision in its previous draft to recommend the limited use of the drug as a second-line treatment for some people whose AF has not been controlled by first-line therapy.
National Institute for Health and Clinical Excellence (Cardiologia) - Gio, 22 Luglio 2010
http://www.nice.org.uk